5th gen glp-1 💉🧬 GLP “5”? The Future of Weight Loss & Metabolic Medicine Is Coming 👀🔥 Move over GLP-1… scientists are now developing QUINTUPLE AGONISTS — drugs designed to target 5 metabolic pathways at INJECTABLE GLP GLP-1 Weight Loss Subscription

Additionally, Teva launched the first generic liraglutide for weight loss in August 2025, offering a lower-cost alternative to branded Saxenda

In December 2025, Eli Lilly announced $3 billion expansion of its Wisconsin facility to meet surging demand for GLP-1 drugs like Zepbound and Mounjaro

dose-response characterisation of GHS-R1a across multiple receptor-mediated outcomes simultaneously

Evaluating the Effects of the Novel GLP-1 Analogue Liraglutide in Alzheimers Disease (ELAD): Phase 2b randomized, double-blind, placebo-controlled trial

Too much and you are wasting peptide while potentially adding unnecessary risk